Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Acta Med Okayama. 2012;66(4):299–305.
WHO. Sepsis [Internet]. 2020 [cited 2021 Sep 17]. Available from: https://www.who.int/news-room/factsheets/detail/sepsis?__cf_chl_captcha_tk__=pmd_kulzVSlRw5lPKCgTWghJW6kI6fErTbbJP0p7HTJ297E-1631864259-0-gqNtZGzNAuWjcnBszQmR
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and National sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;18(10219):200–11.
Sakr Y, Jaschinski U, Wittebole Xavier, Szakmany T, Lipman J, Ñamendys-Silva SA, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018. https://doi.org/10.1093/ofid/ofy313.
Google Scholar
Kiya GT, Mekonnen Z, Melaku T, Tegene E, Gudina EK, Cools P, et al. Prevalence and mortality rate of sepsis among adults admitted to hospitals in sub-Saharan Africa: a systematic review and meta-analysis. J Hosp Infect. 2024;144:1–13.
Google Scholar
Dolin HH, Papadimos TJ, Chen X, Pan ZK. Characterization of pathogenic sepsis etiologies and patient profiles: a novel approach to triage and treatment. Microbiol Insights. 2019;12(Fig 1):117863611882508.
Saharman YR, Karuniawati A, Severin JA, Verbrugh HA. Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review. Antimicrob Resist Infect Control. 2021;10(1):1–19.
Gouel-Cheron A, Swihart BJ, Warner S, Mathew L, Strich JR, Mancera A, et al. Epidemiology of ICU-onset bloodstream infection: prevalence, pathogens, and risk factors among 150,948 ICU patients at 85 U.S. hospitals. Crit Care Med. 2022;50(12):1725.
Google Scholar
Kontopoulou K, Tsepanis K, Sgouropoulos I, Triantafyllidou A, Socratous D, Tassioudis P, et al. Risk factors associated with acinetobacter baumannii septicemia and its mortality rates in critically ill patients. Crit Care 2013 172. 2013;17(2):1–200.
Fentie A, Wondimeneh Y, Balcha A, Amsalu A, Adankie BT. Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at university of Gondar hospital, Northwest Ethiopia. Infect Drug Resist. 2018;11:2169–78.
Google Scholar
Lan M, Dongmei K, Guodong S, Haifeng Y, Guofeng C, Mengting C, et al. Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia. BMC Infect Dis. 2024;24(1):1–10.
Stephen AH, Montoya RLAA. Sepsis and septic shock in low- and middle-income countries. Surg Infect. 2020;21(7):571–8.
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47.
Google Scholar
Tosi M, Roat E, De Biasi S, Munari E, Venturelli S, Coloretti I, et al. Multidrug resistant bacteria in critically ill patients: a step further antibiotic therapy. J Emerg Crit Care Med. 2018;2:103–103.
MJ IL, MH DAS. A multicenter, prospective, observational study to determine predictive factors for Multidrug-Resistant pneumonia in critically ill adults: the DEFINE study. Pharmacotherapy. 2019;39(3):253–60.
Chakraborty M, Sardar S, De R, Biswas M, Mascellino MT, Miele MC, et al. Current trends in antimicrobial resistance patterns in bacterial pathogens among adult and pediatric patients in the intensive care unit in a tertiary care hospital in Kolkata, India. Antibiotics. 2023;12(3):459.
Google Scholar
Agaba P, Tumukunde J, Tindimwebwa JVB, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes. 2017;10(1):1–12.
Bandić Pavlović D, Pospišil M, Nađ M, Vrbanović Mijatović V, Luxner J, Zarfel G, et al. Multidrug-resistant bacteria in surgical intensive care units: antibiotic susceptibility and β-lactamase characterization. Pathogens. 2024;13(5):411.
Google Scholar
Li Q, Zhou X, Yang R, Shen X, Li G, Zhang C, et al. Carbapenem-resistant Gram-negative bacteria (CR-GNB) in ICUs: resistance genes, therapeutics, and prevention – a comprehensive review. Front Public Health. 2024;12: 1376513.
Google Scholar
Beshah D, Desta AF, Woldemichael GB, Belachew EB, Derese SG, Zelelie TZ, et al. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia. PLoS One. 2023. https://doi.org/10.1371/journal.pone.0287453.
Google Scholar
Tilahun M, Sharew B, Shibabaw A. Antimicrobial resistance profile and associated factors of hospital-acquired gram-negative bacterial pathogens among hospitalized patients in Northeast Ethiopia. BMC Microbiol. 2024;24(1):1–17.
Sid Ahmed MA, Bansal D, Acharya A, Elmi AA, Hamid JM, Sid Ahmed AM, et al. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control. 2016;5(1):1–6.
Alebel M, Mekonnen F, Mulu W. Extended-spectrum β-lactamase and carbapenemase producing Gram-negative bacilli infections among patients in intensive care units of Felegehiwot referral hospital: a prospective cross-sectional study. Infect Drug Resist. 2021;14:391.
Google Scholar
Gashaw M, Gudina EK, Ali S, Gabriele L, Seeholzer T, Alemu B, et al. Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma medical center, Ethiopia. Front Microbiol. 2024;15:1336387.
Google Scholar
Tigabie M, Ayalew G, Demoze L, Tadesse K, Gashaw Y, Assefa M. Extended-spectrum beta-lactamase and carbapenemase-producing gram-negative bacteria in urinary tract infections in Ethiopia: a systematic review and meta-analysis. BMC Urol. 2025;25(1):1–19.
Alemayehu E, Fiseha T, Gedefie A, Alemayehu Tesfaye N, Ebrahim H, Ebrahim E, et al. Prevalence of carbapenemase-producing Enterobacteriaceae from human clinical samples in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2023. https://doi.org/10.1186/s12879-023-08237-5.
Google Scholar
Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care. 2011;1(1):47.
Google Scholar
Mulatu HA, Bayisa T, Worku Y, Lazarus JJ, Woldeyes E, Bacha D, et al. Prevalence and outcome of sepsis and septic shock in intensive care units in Addis Ababa, Ethiopia: a prospective observational study. Afr J Emerg Med. 2021;11(1):188–95.
Google Scholar
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. 2024.
AMPC ESBL DETECTION SET [Internet]. [cited 2025 Apr 14]. Available from: https://www.mast-group.com/uk/products/amr/antibiotic-resistance-detection-sets/d68c/
MASTDISCS COMBI CARBA PLUS [Internet]. [cited 2025 Apr 14]. Available from: https://www.mast-group.com/uk/products/amr/antibiotic-resistance-detection-sets/d73c/
Ohsaki Y, Kubo R, Hobson J, Davies M, Osaka S, Hayashi W, et al. MASTDISCS combi carba plus, a simple method for discriminating carbapenemase-producing enterobacteriaceae, including OXA-48-type producers. Microbiol Immunol. 2018;62(1):60–5.
Google Scholar
Mitharwal SM, Yaddanapudi S, Bhardwaj N, Gautam V, Biswal M, Yaddanapudi L. Intensive care unit-acquired infections in a tertiary care hospital: an epidemiologic survey and influence on patient outcomes. Am J Infect Control. 2016;44(7):e113-7.
Google Scholar
Iliyasu G, Daiyab FM, Tiamiyu AB, Abubakar S, Habib ZG, Sarki AM, et al. Nosocomial infections and resistance pattern of common bacterial isolates in an intensive care unit of a tertiary hospital in Nigeria: a 4-year review. J Crit Care. 2016;34:116–20.
Google Scholar
Litwin A, Fedorowicz O, Duszynska W. Characteristics of microbial factors of Healthcare-Associated infections including Multidrug-Resistant pathogens and antibiotic consumption at the university intensive care unit in Poland in the. Int J Environ Res Public Heal. 2020;17:6943.
Google Scholar
Wani FA, Bandy A, Alenzi MJS, Alzarea AI, Alanazi AS, Sayeed MU, et al. Resistance patterns of gram-negative bacteria recovered from clinical specimens of intensive care patients. Microorganisms. 2021;9(11):2246.
Google Scholar
Iwuafor AA, Ogunsola FT, Oladele RO, Oduyebo OO, Desalu I, Egwuatu CC, et al. Incidence, clinical outcome and risk factors of intensive care unit infections in the Lagos university teaching hospital (LUTH), Lagos, Nigeria. PLoS One. 2016;11(10):e0165242.
Google Scholar
Ture Z, Güner R, Alp E. Antimicrobial stewardship in the intensive care unit. J Intensive Med. 2023;3(3):244–53.
Google Scholar
Calvo M, Stefani S, Migliorisi G. Bacterial Infections in Intensive Care Units: Epidemiological and Microbiological Aspects. Antibiot 2024, Vol 13, Page 238. 2024;13(3):238.
Siddique SG, Bhalchandra MH, Wyawahare AS, Bansal VP, Mishra JK, Naik SD. Prevalence of MRSA, ESBL and carbapenemase producing isolates obtained from endotracheal and tracheal tubes secretions of ICU patient at tertiary care centre. IntJCurrMicrobiolAppSci. 2017;6(4):288–99.
Google Scholar
Beshah D, Desta AF, Woldemichael GB, Belachew EB, Derese SG, Zelelie TZ, et al. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia. PLoS One. 2023;18(6):e0287453.
Google Scholar
Gupta R, Malik A, Rizvi M, Ahmed M. Presence of metallo-beta-lactamases (MBL), extended-spectrum beta-lactamase (ESBL) & AmpC positive non-fermenting Gram-negative bacilli among intensive care unit patients with special reference to molecular detection of blaCTX-M & BlaAmpC genes. Indian J Med Res. 2016;144(2):271–5.
Google Scholar
Yuan L, Qin P, Qangqiang LBC. Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections. Int Urol Nephrol. 2025;57(4).
Teklu DS, Negeri AA, Legese MH, et al. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8:39.
Google Scholar
Bahrami S, Shafiee F, Hakamifard A, Fazeli HSR. Antimicrobial susceptibility pattern of carbapenemase-producing gram-negative nosocomial bacteria at al Zahra hospital, Isfahan, Iran. Iran J Microbiol. 2021;13(1):50–7.
Google Scholar
Aishwarya JRIV. Prevalence and antimicrobial susceptibility pattern of carbapenemase producing Gram-Negative bacterial isolates. J Res Med Dent Sci. 2021;9(6):140–9.
Ibrahim ME. High antimicrobial resistant rates among Gram-negative pathogens in intensive care units: a retrospective study at a tertiary care hospital in Southwest Saudi Arabia. Saudi Med J. 2018;39(10):1035.
Google Scholar
Tran GM, Ho-Le TP, Ha DT, Tran-Nguyen CH, Nguyen TSM, Pham TTN, et al. Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. BMC Infect Dis. 2017;17(1):429.
Google Scholar
Dawit TC, Mengesha RE, Ebrahim MM, Tequare MH, Abraha HE. Nosocomial sepsis and drug susceptibility pattern among patients admitted to adult intensive care unit of Ayder Comprehensive Specialized Hospital, Northern Ethiopia. BMC Infect Dis. 2021. https://doi.org/10.1186/s12879-021-06527-4.
Google Scholar
Fizza K, Christy P, Azza E, Abid M, Osamah TK. Spectrum of isolates and antimicrobial susceptibility pattern from blood cultures in tertiary care hospital, Riyadh. J Pure Appl Microbiol. 2025. https://doi.org/10.22207/JPAM.19.2.03.
Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, et al. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents. 2011;38(4):331–5.
Google Scholar
Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med. 2002;162(19):2229–35.
Google Scholar
Marwan J, Alwazzeh J, Algazaq FA, Al-Salem F, Alabkari SM, Alwarthan M, Alhajri BM, AlShehail. Amani Alnimr, Ahmad Wajeeh Alrefaai FHA& FAA. Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by Multidrug-resistant Acinetobacter baumannii in critically ill patients. 25, 416 (2025). BMC Infect Dis. 2025;25(416).
SS. Multidrug resistance in critically ill patients: an unresolved issue. Microorganisms. 2023;11(4):946.
L MF. Antimicrobial resistance in acinetobacter baumannii: from bench to bedside. WJCC. 2014;2(12):787.
Fernández-Martínez NF, Cárcel-Fernández S, De la Fuente-Martos C, Ruiz-Montero R, Guzmán-Herrador BR, León-López R, Gómez FJ, Guzmán-Puche J, Martínez-Martínez. L S-LI. Risk factors for Multidrug-Resistant Gram-Negative bacteria carriage upon admission to the intensive care unit. Int J Env Res Public Heal. 2022;19(3):1039.
Scheer CS, Fuchs C, Rehberg S, Bast J, Vollmer M, Balau V, et al. Incidence of pathogen detection in blood cultures of severe sepsis and septic shock patients is higher, if blood cultures were drawn before anti-infective therapy. Intensive Care Med Exp. 2015;3(Suppl 1):A882.
Google Scholar
Cheng MP, Stenstrom R, Paquette K, Stabler SN, Akhter M, Davidson AC, et al. Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann Intern Med. 2019;171(8):547–54.
Google Scholar
Scheer CS, Fuchs C, Gründling M, Vollmer M, Bast J, Bohnert JA, et al. Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study. Clin Microbiol Infect. 2019;25(3):326–31.
Google Scholar
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247.
Google Scholar
Zornitzki L, Anuk L, Frydman S, Morag-Koren N, Zahler D, Freund O, et al. Rate and predictors of blood culture positivity after antibiotic administration: a prospective single-center study. Infection. 2024;52(2):483–90.
Google Scholar
Rand KH, Beal SG, Rivera K, Allen B, Payton T, Lipori GP. Hourly effect of pretreatment with IV antibiotics on blood culture positivity rate in emergency department patients. Open Forum Infect Dis. 2019;6(5): ofz179.
Google Scholar
Yang L, Lin Y, Wang J, Song J, Wei B, Zhang X, et al. Comparison of clinical characteristics and outcomes between positive and negative blood culture septic patients: A retrospective cohort study. Infect Drug Resist. 2021;144191–205
Google Scholar
Armstrong-Briley D, Hozhabri NST, Armstrong K, Puthottile J, Benavides R, Beal S. Comparison of length of stay and outcomes of patients with positive versus negative blood culture results. Baylor Univ Med Cent Proc. 2015;28(1):10–3.
Li Y, Guo J, Yang H, Li H, Shen Y, Zhang D. Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2021;25(1):1–9.